Medibio
Medibio is a mental health technology company focused on developing objective measures to aid in the diagnosis, monitoring, and management of mental health conditions such as depression and stress. The company aims to revolutionize mental health care through innovative biometrics and digital health solutions, including wearable technology and clinical decision support systems, with a mission to improve diagnostic accuracy, reduce stigma, and provide personalized care.
Industries
Nr. of Employees
small (1-50)
Patents
Products
Mobile application for wearable data processing and individual reports
Mobile app that connects to consumer and clinical wearable devices to import sleep, activity and heart-rate data, process signals with diagnostic algorithms, and deliver individualized biometric reports and daily feedback.
Mobile application for wearable data processing and individual reports
Mobile app that connects to consumer and clinical wearable devices to import sleep, activity and heart-rate data, process signals with diagnostic algorithms, and deliver individualized biometric reports and daily feedback.
Services
Enterprise deployment of employee mental health check-ins using wearable-derived physiological data combined with online assessments to provide individual reports and de-identified organisational analytics.
Provision of clinician-facing decision support combining wearable-derived biomarkers and algorithmic outputs to assist assessment and monitoring of depressive episodes and other mental health conditions.
Enterprise deployment of employee mental health check-ins using wearable-derived physiological data combined with online assessments to provide individual reports and de-identified organisational analytics.
Provision of clinician-facing decision support combining wearable-derived biomarkers and algorithmic outputs to assist assessment and monitoring of depressive episodes and other mental health conditions.
Expertise Areas
- Digital biomarker development (HRV and sleep)
- Clinical trial management and multi-site validation
- Machine learning for clinical prediction
- Wearable data integration and consumer device compatibility
Key Technologies
- Heart rate variability (HRV) analysis
- Circadian heart rhythm monitoring
- Overnight sleep physiology monitoring
- Wearable sensor data ingestion (APIs)
News & Updates
Claude Solitario, Managing Director & CEO of Medibio, gives an introduction to Medibio and how they are pioneering the use of objective measures to aid in mental health diagnosis.
Highlights Medibio is among the healthcare stocks to consider in October 2021, with a focus on its innovative mental health solutions.
Medibio launched LUCA, a mobile application for stress management, integrating biometric data and online assessments.
An article discussing how biometric data from Medibio's technology provides insights into staff wellbeing and organizational health.
A valuation report on Medibio, highlighting its potential and market position.
A press release about how Medibio's ilumen™ technology helps organizations like Stantec support staff mental health.
Claude Solitario, Managing Director & CEO of Medibio, gives an introduction to Medibio and how they are pioneering the use of objective measures to aid in mental health diagnosis.
Highlights Medibio is among the healthcare stocks to consider in October 2021, with a focus on its innovative mental health solutions.
Medibio launched LUCA, a mobile application for stress management, integrating biometric data and online assessments.
An article discussing how biometric data from Medibio's technology provides insights into staff wellbeing and organizational health.
A valuation report on Medibio, highlighting its potential and market position.
A press release about how Medibio's ilumen™ technology helps organizations like Stantec support staff mental health.